{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:05:40Z","timestamp":1760187940350},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[1999,6]]},"DOI":"10.1016\/s0145-2126(99)00045-4","type":"journal-article","created":{"date-parts":[[2002,10,14]],"date-time":"2002-10-14T20:48:11Z","timestamp":1034628491000},"page":"549-557","source":"Crossref","is-referenced-by-count":38,"title":["Autoimmune disease induced by dendritic cell immunization against leukemia"],"prefix":"10.1016","volume":"23","author":[{"given":"Marie A.","family":"Roskrow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Dilloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanyung","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cliona M.","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm K.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0145-2126(99)00045-4_BIB1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","article-title":"The dendritic cell system and its role in immunogenicity","volume":"9","author":"Steinman","year":"1991","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nm0196-52","article-title":"Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells","volume":"2","author":"Hsu","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/(SICI)1097-0045(199612)29:6<371::AID-PROS5>3.0.CO;2-B","article-title":"Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen","volume":"29","author":"Murphy","year":"1996","journal-title":"Prostate"},{"key":"10.1016\/S0145-2126(99)00045-4_BIB4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nm0597-558","article-title":"Induction of antitumor acitvity by immunization with fusions of dendritic and carcinoma cells","volume":"3","author":"Gong","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB5","first-page":"3763","article-title":"Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1)","volume":"56","author":"Henderson","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB6","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/eji.1830260803","article-title":"Peptide-pulsed dedritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from Melan-A\/MART-1 self antigen","volume":"26","author":"van-Elsas","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1084\/jem.183.1.283","article-title":"Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity","volume":"183","author":"Celluzzi","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0065-2776(08)60431-9","article-title":"Human tumor antigens are ready to fly","volume":"62","author":"Henderson","year":"1996","journal-title":"Adv. Immunol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1084\/jem.183.3.725","article-title":"Human tumor antigens recognized by T lymphocytes","volume":"183","author":"Boon","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1084\/jem.183.1.317","article-title":"Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo","volume":"183","author":"Paglia","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1084\/jem.184.2.465","article-title":"Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo","volume":"184","author":"Boczkowski","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.178.2.669","article-title":"CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40","volume":"178","author":"Alderson","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB13","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1073\/pnas.87.19.7698","article-title":"The distinct surface of human blood dendritic cells as observed after an improved isolation method","volume":"87","author":"Freudenthal","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0145-2126(99)00045-4_BIB14","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1084\/jem.180.4.1263","article-title":"Activation of human dendritic cells through CD40 cross-linking","volume":"180","author":"Caux","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB15","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4049\/jimmunol.152.4.1523","article-title":"CD40 preferentially costimulates activation of CD4+ T lymphocytes","volume":"152","author":"Cayabyab","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB16","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1002\/eji.1830241235","article-title":"Role of the CD40\u2013CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis","volume":"24","author":"Wagner","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB17","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.4049\/jimmunol.152.9.4262","article-title":"Recombinant CD40 ligand exerts potent biologic effects on T cells","volume":"152","author":"Fanslow","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB18","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1002\/eji.1830230941","article-title":"CD40 ligand is a T cell growth factor","volume":"23","author":"Armitage","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0092-8674(94)90332-8","article-title":"Lymphocyte responses and cytokines","volume":"76","author":"Paul","year":"1994","journal-title":"Cell"},{"key":"10.1016\/S0145-2126(99)00045-4_BIB20","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1182\/blood.V90.5.1927","article-title":"CD40 ligand acts as a co-stimulator molecule for the generation of an anti-tumor immune response","volume":"90","author":"Dilloo","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(99)00045-4_BIB21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4049\/jimmunol.122.2.549","article-title":"Establishment and characterization of BALB\/c lymphoma lines with B cell properties","volume":"122","author":"Kim","year":"1979","journal-title":"J. Immunol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/276510a0","article-title":"Transformed cell lines susceptible or resist to in vivo surveillance against tumorigenesis","volume":"276","author":"Patek","year":"1978","journal-title":"Nature"},{"key":"10.1016\/S0145-2126(99)00045-4_BIB23","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1128\/JVI.61.5.1639-1646.1987","article-title":"Evidence that the packaging signal of Moloney, Murine Leukemia Virus extends into the gag region","volume":"61","author":"Bender","year":"1987","journal-title":"J. Virol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB24","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/0140-6736(93)92122-A","article-title":"Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients","volume":"342","author":"Brenner","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/S0145-2126(99)00045-4_BIB25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/hum.1992.3.6-665","article-title":"Phase I study of cytokine-gene modified autologous neuroblastoma cells for treatment of relapsed\/refractory neuroblastoma","volume":"3","author":"Brenner","year":"1992","journal-title":"Hum. Gene. Ther."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0076-6879(93)17061-9","article-title":"Cell-free expression of large collections of cDNA clones using positive-selection I phage vectors","volume":"217","author":"Coleclough","year":"1993","journal-title":"Meth. Enzymol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB27","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.1073\/pnas.90.18.8392","article-title":"Production of high-titer helper-free retroviruses by transient transfection","volume":"90","author":"Pear","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0145-2126(99)00045-4_BIB28","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.4049\/jimmunol.131.5.2445","article-title":"Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5; similarity of L3T4 molecule","volume":"131","author":"Dialynas","year":"1983","journal-title":"J. Immunol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB29","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.4049\/jimmunol.125.6.2665","article-title":"IgG of IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing LYT 2 antigen block T cell-mediated cytolysis in the absence of complement","volume":"125","author":"Sarmiento","year":"1980","journal-title":"J. Immunol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB30","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1084\/jem.183.5.2313","article-title":"The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help","volume":"183","author":"Fulcher","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB31","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJM199103073241005","article-title":"Graft\u2013versus\u2013host disease","volume":"324","author":"Ferrara","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00043426-199302000-00003","article-title":"Biology of graft\u2013versus\u2013host disease","volume":"15","author":"Korngold","year":"1993","journal-title":"Am. J. Ped. Hem\/Onc."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB33","first-page":"51","article-title":"Contribution of CD4+and CD8+T cells to graft\u2013versus-host-disease and graft\u2013versus\u2013leukemia reactivity after transplantation of MHC-compatible bone marrow","volume":"8","author":"Truitt","year":"1991","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.181.2.641","article-title":"Greatly reduced lymphoproliferation in lrp mice lacking major histocompatibility complex class I","volume":"181","author":"Maldonado","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0167-5699(95)80125-1","article-title":"Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy","volume":"16","author":"Grabbe","year":"1995","journal-title":"Immunol. Today"},{"key":"10.1016\/S0145-2126(99)00045-4_BIB36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1097-0045(199601)28:1<65::AID-PROS9>3.0.CO;2-N","article-title":"Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity","volume":"28","author":"Tjoa","year":"1996","journal-title":"Prostate"},{"key":"10.1016\/S0145-2126(99)00045-4_BIB37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-065X.1993.tb01513.x","article-title":"Death and T cells","volume":"133","author":"Marrack","year":"1993","journal-title":"Immunol. Rev."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB38","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0952-7915(92)90006-Z","article-title":"Thymic Selection","volume":"4","author":"Pardoll","year":"1992","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB39","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/eji.1830100310","article-title":"Thymus cell migration: Quantitative aspects of cellular traffic from the thymus to the periphery in mice","volume":"10","author":"Scollay","year":"1980","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB40","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1084\/jem.179.4.1127","article-title":"Turnover of naive-and memory-phenotype T cells","volume":"179","author":"Tough","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/371389a0","article-title":"Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire","volume":"371","author":"Cyster","year":"1994","journal-title":"Nature"},{"key":"10.1016\/S0145-2126(99)00045-4_BIB42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/08916939608995354","article-title":"Differential involvement of Th1 and Th2 cytokines in autoimmune disease","volume":"24","author":"Kroemer","year":"1996","journal-title":"Autoimmunity"},{"key":"10.1016\/S0145-2126(99)00045-4_BIB43","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.4049\/jimmunol.153.11.4925","article-title":"Phagocytic processing of exogenous particulate antigen by macrophages for presentation by class I MHC molecules","volume":"153","author":"Harding","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4049\/jimmunol.148.1.13","article-title":"MHC class I restricted presentation of exogenous antigen by thymic antigen-presenting cells in vitro and in vivo","volume":"148","author":"Grant","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB45","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1084\/jem.182.3.841","article-title":"Major histocompatibility complex class I presentation peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis","volume":"182","author":"Reis","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB46","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1084\/jem.143.5.1283","article-title":"Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay","volume":"143","author":"Bevan","year":"1976","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB47","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1084\/jem.184.3.923","article-title":"Constitutive class I-restricted exogenous presentation of self-antigens in vivo","volume":"184","author":"Kurts","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB48","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1126\/science.7539551","article-title":"Identification of a graft versus host disease-associated human minor histocompatibility antigen","volume":"268","author":"Den Haan","year":"1995","journal-title":"Science"},{"key":"10.1016\/S0145-2126(99)00045-4_BIB49","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.184.2.747","article-title":"Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity:T-T help via APC activation","volume":"184","author":"Cella","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB50","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1084\/jem.184.2.741","article-title":"High level IL-12 production by murine dendritic cells: upregulation via MHC class Il and CD40 molecules and downregulation by IL-4 and IL-10","volume":"184","author":"Koch","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB51","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/art.1780371113","article-title":"Elevated expression of CD80 (B7.1) and other accessory molecules on synovial fluid mononuclear cell subsets in rheumatoid arthritis","volume":"37","author":"Ranheim","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB52","first-page":"231","article-title":"Expression of the costimulatory molecule B7\/BB1 antigen in autoimmune thyroid disease","volume":"87","author":"Tandon","year":"1994","journal-title":"Quart. J. Med."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB53","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0952-7915(95)80115-4","article-title":"Analysis of lymphocyte costimulation in vivo using transgenic and \u2018knockout\u2019 mice","volume":"7","author":"Sharpe","year":"1995","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB54","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1073\/pnas.91.11.5138","article-title":"Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor (leads to autoimmunity in transgenic mice","volume":"91","author":"Guerder","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB55","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.4049\/jimmunol.157.7.3159","article-title":"Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black\u00d7New Zealand white mice. Response correlates with the absence of an anti-antibody response","volume":"157","author":"Early","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB56","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.4049\/jimmunol.160.5.2158","article-title":"Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function","volume":"160","author":"Kalled","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB57","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.7689748","article-title":"Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40","volume":"261","author":"Durie","year":"1993","journal-title":"Science"},{"key":"10.1016\/S0145-2126(99)00045-4_BIB58","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1073\/pnas.93.6.2499","article-title":"CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis","volume":"19","author":"Gerrits","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/S0145-2126(99)00045-4_BIB59","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood.V88.7.2450.bloodjournal8872450","article-title":"Targeted T-cell therapy for human leukemia: Cytotoxic T lymphocytes specific for a peptide derived from Proteinase 3 preferentially lyse human myeloid leukemia cells","volume":"88","author":"Molldrem","year":"1996","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(99)00045-4_BIB60","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1073\/pnas.91.6.2105","article-title":"Induction of anti-tumor cytotoxic T lymphocytes in normal-humans using primary cultures and synthetic peptide epitopes","volume":"91","author":"Celis","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212699000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212699000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,9]],"date-time":"2023-04-09T18:02:45Z","timestamp":1681063365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212699000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1999,6]]}},"alternative-id":["S0145212699000454"],"URL":"https:\/\/doi.org\/10.1016\/s0145-2126(99)00045-4","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[1999,6]]}}}